← SynDRA
Tocris-0832
SynDRA canonical compound SYN0957586 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 PARTIAL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ATAD5
- BRCA1
- EHMT2
- NFE2L2
- NPC1
- RAB9A
- TDP1
- TP53
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic beta-Antagonists
Cross-references
Synonyms
- NCGC00024811-01
- AKOS024458663
- PDSP2_000652
- HY-15726
- A11561
- AS-56053
- NCGC00024811-02
- HMS3678I15
- MFCD00673934
- ici-89406
- BRD-A03359064-001-02-3
- ICI-89406
- UNII-C027IY98WE
- LCI 89406
- RefChem:923282
- CS-0008550
- BDBM25748
- HMS3414I15
- SCHEMBL9798766
- ici89406
- T22852
- C027IY98WE
- ICI89406;ICI-89406
- Ici-89406
- Ici 89 406
- BRD-A03359064-001-01-5
- PDSP1_000661
- GTPL12581
- orb1305793
- SR-01000597450
- CHEBI:91488
- HMS3266H22
- SR-01000597450-1
- DCA67171
- DA-74400
- ICI 89,406
Look up Tocris-0832 in the interactive SynDRA portal →